Hospital background

How to Talk to Your Doctor About CAR T Cell Therapy

Understanding your treatment options and having informed conversations with your healthcare team is the first step toward making the best decision for your care.

The Following Information Is Provided by These Patient Advocacy Organizations

International Myeloma Foundation logo
BMT InfoNet logo
Leukemia & Lymphoma Society logo
CancerCare logo
Lazarex Cancer Foundation logo
HealthTree Foundation logo
CLL Society logo
Lymphoma Research Foundation logo
Black Health Matters logo
Multiple Myeloma Research Foundation logo
Blood Cancer United logo
Cancer Support Community logo
American Cancer Society logo
International Myeloma Foundation logo
BMT InfoNet logo
Leukemia & Lymphoma Society logo
CancerCare logo
Lazarex Cancer Foundation logo
HealthTree Foundation logo
CLL Society logo
Lymphoma Research Foundation logo
Black Health Matters logo
Multiple Myeloma Research Foundation logo
Blood Cancer United logo
Cancer Support Community logo
American Cancer Society logo

Overcoming CAR-T Barriers

Get answers to common questions about CAR-T cell therapy

CAR-T Therapy: Myths vs Facts

Separating fact from fiction about CAR-T cell therapy

CAR T is used only after all other treatments have failed

CAR T is not a "last option." In fact, some CAR T therapies can now be used to treat patients earlier in their disease.

CAR T is not a "last option"

CAR T is not a "last option." In fact, some CAR T therapies can now be used to treat patients earlier in their disease.

CAR T-cell therapy replaces a stem cell transplant

CAR T may be a treatment option for patients who are not candidates for stem cell therapy. Other patients may eventually have both a stem cell transplant and CAR T.

CAR T may be an alternative or complement to stem cell transplant

CAR T may be a treatment option for patients who are not candidates for stem cell therapy. Other patients may eventually have both a stem cell transplant and CAR T.

CAR T cell therapy is only for younger patients

CAR T cell therapy has been shown to be an effective therapeutic option for both younger and older patients, with similar response rates. Patients may not be candidates if they have had frequent infections or hospitalizations, end stage renal disease, or cardiovascular disease.

CAR T is effective for both younger and older patients

CAR T cell therapy has been shown to be an effective therapeutic option for both younger and older patients, with similar response rates. Patients may not be candidates if they have had frequent infections or hospitalizations, end stage renal disease, or cardiovascular disease.

The side effects of CAR T are severe and difficult to manage

CAR T therapy side effects can be serious, but doctors have made a lot of progress in understanding how to manage them both in the hospital and within local community clinics.

Side effects are manageable with proper care

CAR T therapy side effects can be serious, but doctors have made a lot of progress in understanding how to manage them both in the hospital and within local community clinics.

Expenses associated with CAR T make this treatment out of reach for many patients

There are financial resources available for people having CAR T therapy both in and out of a clinical trial. These resources may include funding, organizations that navigate work or caregiver challenges, insurance and treatment related costs. Speak with your team about oncology social workers or financial navigators to help find out more.

Financial assistance is available

There are financial resources available for people having CAR T therapy both in and out of a clinical trial. These resources may include funding, organizations that navigate work or caregiver challenges, insurance and treatment related costs. Speak with your team about oncology social workers or financial navigators to help find out more.